Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

Jul 20, 2018
AHA letter to the Senate expressing support for Robert Wilkie Department.of Veteran Affairs Nomination.
Jul 17, 2018
AHA expresses disappointment that the Agency for Healthcare Research and Quality is shutting down the National Guidelines Clearinghouse.
Jul 17, 2018
AHA, health organizations letter to CMS regarding its decision to suspend billions of dollars in annual payments to insurers as required under the Affordable Care Act’s risk-adjustment program.
Jul 16, 2018
AHA comments on the 340B section of the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Jul 16, 2018
AHA comments on the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Jul 12, 2018
AHA commends MedPAC and HHS for voicing significant concerns about rising pharmaceutical costs. 
Jul 11, 2018
AHA provides comments on the consumer-directed health plan legislation being marked up in the Committee on Ways & Means.
Jul 10, 2018
The AHA is very pleased that CMS is taking action to improve the operation of the Stark law and counteract its chilling effect on innovation.
Jun 28, 2018
The AHA urges the Centers for Medicare & Medicaid Services to expand the data it makes available through standard analytic files and to share currently available data on a timelier basis.
Jun 26, 2018
The AHA appreciates the extensive work CMS has done to develop and alternative to the current SNF case-mix system. However, our evaluation of the patient-driven payment model still has several flaws, which must be addressed before the PDPM proposal can be finalized.